Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNUlRaTkNWVU9RTmRlS2xFWWNlMS1peXQ5U3lKSS1JZ0dFSlhkUEhmWlQ0NlR3cVdLTDc3YlZtSFBveVc1V1VUbVRFWkdmREViTjZWNVJWb2ZOVUItNHp6RW1JRzBQeWdUZExFaGpKMnV5ajJ1b1cyZkdzb3VodlBVMm11cmc1a3VZZS1yQlNLQktzZG1ET0hQREZzUHg2VEdQWGNiTg?oc=5" target="_blank">Preclinical Study Reveals How Repeated Exposures May Make Allergies Worse</a>&nbsp;&nbsp;<font color="#6f6f6f">Harvard Medical School</font>
Premier League LIVE: Coventry City vs Newcastle United - build-up, team news, score, text commentary & match stats
Levante - Sevilla en directo
"La cosa se está poniendo tensa": manifestantes se enfrentan a agentes migratorios en Oregon
Indigo Girls cancel show after tour bus driver dies in highway crash
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBMZUR6VFBHWTczV1dWR3JyQUNXTXo3d2tsZXFwM0hPcHhtOTNQUmNKQmFSRjhLbVhLY0NRVjBxWndnLVltUWJhS3ZWa0d6bkxfMVpyeEFFUDJDNm4tbGlB?oc=5" target="_blank">Linking tumor viability and immune infiltration with dual-nucleus MRI in preclinical models</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNQU5jblo5MjV2aGFERktDcTVfalNLRzF4d2xuSmtHNjFJNzUzT1JUdDZ0M1RCc0FobDJubG15NHlsdTJhbnlhcFhvWnRISm9fbzFkSzJPdnVPOWdTYTgxZUcwbVJOOEpBR3Z0SXM4QWZkbmlVUWw0Rzh2cFlPajBmUFNHdEpDeUplbENBZHowZlM1QQ?oc=5" target="_blank">Editorial: Cell models and preclinical validation of immune-mediating biological therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOckRlT1pIVUVOQ2l1M3B3RmZNN0JwRG8ybTF4Z1FQQkl3enhzWGZUb3pDdlR0a1loYVl2aXB4Q0ZYSjE3N0tQbEJqZ2xIY1ZVenhMcklmaEhKODh2SEIyeElIN2RPRlRCTG5jWUtqUFN4UHRsMUY1TUYwM3RyOUpmTm5fOUZMOWhaclE?oc=5" target="_blank">Magnetic pulses reprogram immune cells to fight breast cancer in preclinical models</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Xpress</font>
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxOb2tDNUE5M3RhbE96S1ZoblRWS21reGZrSU13VU1raE41RWJTR19ad1hicEpfT2ZOd3VhLVA2TllVbFFDLUlYZjJQUkhHd3B2eGRLV3FQWnJZY0thT1NvWkJOcng3d29iZHpnSDMyUTJuN01DUWlkaTM5ai11aFFxdjk5LXh6NDJ5a2xKRlh3cGlLRkZVNnBJMFRCYzI5OHMwTXlBMDQwb1JTUEJEMk5UelA1Z2RDVnNRUzdGNHliaGJoWGs2aUZ1MQ?oc=5" target="_blank">La Jolla Institute for Immunology: New HIV vaccine shows unprecedented success in preclinical study</a>&nbsp;&nbsp;<font color="#6f6f6f">European AIDS Treatment Group</font>
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQeVZFS0dUamdSb0hrbFE2YkROQ0VpZDg5cjYxYVJlNnhsTVhsZktpNlZOX0w5c3l5bnAxMC1QYnFBS3pxRTlHZnE4ME94WUx6TzFqQ2RTaXdQUFdlYWJPeFk3QmRfRzk0RGFuT0IxMDctanJqZFlsQkp1eWhtZGpRZWFWMEo4Xy1uU0YyRkV6TVpTQ0hpVTZtSlhsNmdJd0pjMVdWOGVzdFJ6MHlvanU3UlM2RGQ0NXRRV0hiWW1uRXlYa3FILWZHTnZDT0hmV3hwZ014UHZXX3dtUUh3VXBqLUl6R0RUUQ?oc=5" target="_blank">Creatine Supplementation in Preclinical Models Receiving Immune Checkpoint Inhibitor Therapy: A Systematic Review</a>&nbsp;&nbsp;<font color="#6f6f6f">The Cureus Journal of Medical Science</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQeGUxaGppdGVPNU5zQUdKVFFsdlF4bFJ5SnVreTAwVy1QM19fT0lYZnZJcEh3QnliMWoyV3RJOVpITkdrbi1BdTJxSHVya21aNndXdDNHNjhmZTJCUFhFWmVnNC1YMEo0RE9Fd2d0b3lMVDd4b0g0azdGVVVqN0x3dXFONGV4SkhuWklPajY5MFNvaTBGcVhjbkZQb285NDBNN3pqcVotYmtRYm9DSWFZ?oc=5" target="_blank">Two-Pronged Immunotherapy Strategy Cracks Glioblastoma’s Defenses in Preclinical Study</a>&nbsp;&nbsp;<font color="#6f6f6f">Bioengineer.org</font>
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPVjg0elBmWWMtMERhZ19KQVhpdTRfUWpqbThmaDVqM0FRaU4tOUdoNXRyM2lsYWVOVWE0ZzkyR051cmVNTXdQMGhYSWxUREdCajZkZ3AwZGRaUi04NUdYa3pSRkoxdFV6dW93bWl6dllibWw3aURpLXg2aWlKR1NYM1Q5bGF4UlU?oc=5" target="_blank">Haisco Licenses Preclinical Immunology Asset to Sentivera | PharmExec</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHd1hjOTZSYS1LODBScHZVeWVIdXdLQnhiV2tSNktCZ2h1dDI3bGZWRGVNR2FRdmFkcXJUWjFXaGY0b2RDandMa01KMEV0OUhKdzJjTi1GeVZFWVIzdERr?oc=5" target="_blank">Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution | Communications Biology</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQUE4wNDROUjNocDJZLUtVZjRwbDFnN1lYeG41QVdOWmFqRlFhVEFIaVV2endUbmU4QUg1YVItZ2FhNGt5bTljVHpiR0RIcXJVSUw5NmxnSC1qMTI3ekF4ZWdNWndaOE9NTkw0Z3hQOTNhVFhuLVNKektoWTA4VU02YXJmczNyWGUyVWNYRGtWV0xsQQ?oc=5" target="_blank">Editorial: Community series in novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer, volume II</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNNFltNkdFZ2Z2TnJmcXJYcUdXalVvUzhadGROMXFEd1BUTnVYeWV5TU1HVThuQkVrN1RMWDVrbm1STHBibTlaMXVzTTVxOUtYUzVweXViZGV4b0JNTUt5aGtlUkhzUFJPSjZSOVJWdy0xZnh5ck9zSEdocDRGS2tHeF9CZUhQc1RXaU8yMWo1QXVUdw?oc=5" target="_blank">Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1xN2dnMks0S1dVbjllNWp6V00wdEpGT3c2UUZjZmlkVVBMRDRGZVJ3cDAxNGlhcVJLMC0wU0o0TEIybjBzSnVlUWNmMW1Bb29RWl9yekI5YnEtNzJXLVBV?oc=5" target="_blank">Dysbiosis-induced expansion of AXL-positive inflammatory type 3 dendritic cells triggers preclinical autoimmunity</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBia1FzejdlWHhtdldNWXlQUDI4NHZWYi1Pcy1yWmV3X3NnMV9ZbnlBcWxvNXlLOHhTQmFQQUVnUmtQd2VFZlc4MEl3cWNKY3AwRE1TREpIOHJ5eVBFYnp3?oc=5" target="_blank">1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) enhances the therapeutic and immunological efficacy of high-dose radiotherapy in preclinical tumor models | Scientific Reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQM0Z3ZUxkbGsyY1NCSXdZa184VFdrLXZSSDJRUWxQTzZKSGItaHp3U3hHRU5QWUFDUmc2NVd4aERJaHRyOHpJZi00dlJhQjhrT09nLW8xZ0d3ZFNwTUcxb0pNQWZ0WkRRakx4QUZ3WUhoV19ZWElBVXp1d19WTk5JSDdGbmJHM1R6M3Z5Zk4tZC1mQQ?oc=5" target="_blank">Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNVV9wS1ZKRVhadklFVUxxZFNUUnRsVUw3ZzlYUGN6U1JYOHl2QWR6Zk9oMk1xb2lYbFZPdjkyc0hGdEtscm1QSlRlR3lIRThNeWhiZW5lOU1KR0h2WEdxenZ5MjlydGRXdEQ0OTZRNndvSzNxa29lRk92TllIMWNBb0M5RlBycnVyNmpOUkZR?oc=5" target="_blank">Immune checkpoint inhibitors in medulloblastoma: current updates in preclinical and clinical developments</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBjMkZHX2VpTlZMa3EzV1BMMEdZNmJBclhPa25WUUhUN1EzTEtjbFVISWpaNVZ6bDFYTlRHY25uS1VpeU5GellKNHl0eGdjdDgzd1JkYlBPTGNMSVA1ZThz?oc=5" target="_blank">Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models | Scientific Reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNQ2ZaQjJvMS1BZEotTWZSd1BvdkZwN3U0QkpNaTJDajJoV3lPaG1leWxrclN1Mi1fMkM3b0l6ZlVxNzdJRkJFOUhZUlpfbF9qODNtRmZHOVpYaHBfUU1vUjFFYWU3U2hRUDVzMFo4SzBRWHdfZ3ZmM1F6N0VLLVFfNkE2LWZNdDJYR1RfWmNkbVBIZw?oc=5" target="_blank">The paradigm shift: re-evaluating preclinical animal models for colorectal cancer in the precision medicine era</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zSUdwR2RFV05rRUJFdHZza1ZtWDJQVmJUR0xaQUc1X3Rha0ptRUJkNUd2bzhIU2h4SWd3cXN1YWRVaG4tVmlYTnhtZHdkSUNOUW5Dd0E2VnJPb25FMl9j?oc=5" target="_blank">Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNVHJPZEZwZUlOTnpyVlhGZ1JYdU11TG1rQ19xeVoyYXdVdC0xZ0daZnhQLUxxc0dqdEhGQ09WbFY5NXhlcGtSR3pTUVdvcFAxZDBZVkdSakhhcWtsc0NMQzVJUGlGSWE3MEVMdDJMdVNCa1hUNlBfRDg5Y3BBeTZqTHo0MV83QktvUURyTkRNaUZnZw?oc=5" target="_blank">Preclinical exploration and current clinical applications of immunotherapeutic strategies for hepatocellular carcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE14S0NBUllzRVcxZHVobTYzY2hsQW8wLUpKNGRfb25ZRG5kRmhvRVJ6QVJFTXhSaEw0QTh1d0tXaURnVlV0VXRtelFZVkZLTF9ZRk5RMHQzQWpEM2puWjhN?oc=5" target="_blank">Boron neutron capture therapy preserves immune cells and induces robust anti-tumour immunity in preclinical mouse model</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNRFMtQ0toZnRLZ19JdXBRSm5sOWlZTHRsdTZnZEg5LXI4S3hQamJXYzVNZGFrTzVRaGFqNlZFNXF5TVoxc3FiSGF0N3RPRGxjekdIbldkVnVJLW9HWEM3dXd0ME44UEFrbTBJVE1RQUUteUFza183Nzl0blFoOW93anNNeDVrMEwxeDc1a2V3RjlRZXh5U3dDVjg1Q3lhRzhzRWpwSQ?oc=5" target="_blank">Biogen inks $1B RayThera buyout to bag immunology assets</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMiwAJBVV95cUxQR0EwUDZHeTJtSEpsTmtsS202eFdzU3VXV1p6amQySDBqS3g4LVlNYmFjYzRYOGVicU9fMWIzcy1VVE5JblFmZlZicTE5Vm5FRzltSlNNbjBwLWJSTVhYdk9aTEo0MXNjZktWSGRNUlc3U1NGRmRzR2tXVEhoYnR5ZFVoLWFlc01nRWdKOVNpRy1sMzVjWmFsejk5enJ4NlpYdDFWYmpRTWwzc3l4VE1XSlFDeTZpdHlscFJXZG9oT21yd2J1SWtfU05HMzNmVW5xSDJ6Y0hRelJEZmpvb2NYN0E5Wk5WenhiLVlKa2U1TjBsQVI3MjVMcGxKWG9PaU1fWFdvWHh6XzFYQUNUa2tkQTMxQWVKV1U0amV0S1NWNmJFckhWZGY2bUUxcGp4Skk2Q3ZPRk5qZzZySFd5RDRaQw?oc=5" target="_blank">Silexion Therapeutics Reports New Positive Preclinical</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOOGpaaG1XLWNURU9RUVFOV2FhT2JSU0UtYVlRVWZxTFVfSzhOUnNfY2Y1bEJQWkRwS0lHUXJuZURDU24zM2M1NzgyWTVwUWVFMlNCWldUREpUZDZXdERYVVN0dGZfTVU0UERhOGVVLW5iYV9ua3NHcTlMbHotcnhCSjRMdkFZWGdqcE4zbkJvcEJWRE5FMEJV?oc=5" target="_blank">Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE5TNld4cmJFejdLZ01QY0dxR0VlWUZPWEkzeW1zeE5LZTJUNmxFVUU3bVp3VzlTUHFpb0JYSTI4dHVrd0Y4NjdUY213dVJacGlKSGNzazRXcFJGc0tpMG1hUVJEY014RGpjYk1ab3hhQlNpQkpKd01MM3drREg?oc=5" target="_blank">Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR and MET Targeting</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncodaily</font>
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzFqbWRuYWJkbWEwcUhRSm4tMkxyWFhhdU41ZWx1UGtrZnZKVmxGS3VqWXpvZlFjWVNHM2hfTTBJU2h4RWxJNVA3SDVJYjdsS2d2LWpyZnk2MlN2clJHMUNMMzFtajZpekhjallLdFJ2RktvcV9JYm9fcFpXTjh3ZDQ3eVZncUJESDByYnhTMzRjTVhPSjdFS2s2aTBXTGY2SzIyTTFFbzdmLWZDclpHRHNjamdrU18wR0E?oc=5" target="_blank">Millions for Preclinical Immunology: Boehringer Teams Up with Immunitas</a>&nbsp;&nbsp;<font color="#6f6f6f">European Biotechnology Magazine</font>
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPY2toSVlBVGhQbEs2RUV2MnFPdnF5ZmtDNVh4VkdWZW1vSVNaek4yd21XOTVTTDF6ZlZTcnVyYThrTEJ3QWJkRm9WZE1WM2Zxdzh6ak1PQ0E5VC1Nb0t1UUt5VnljaXllYVplMFExSEJ4dml5QmhMWGRMV1ptVDlyVGVkR1RfS3M1eDJsTk9nVWxxWlROR3U1LWdqeV82SVRkQ0UzeFA2QjMxQTB0X3VqdXUydkM4VkwtUFE3QmlEWldmcVVGdkVHS01aSV9VUQ?oc=5" target="_blank">Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxONVZQRF9hNHRaaktDYVBSZHVmMG53dFhzYUQ3SmhZY0NSNkx2RWo5YksxRVJJUXBncWt0Q3doXzBEdVQyU0VxUnE4TWJlYmFEOWloRng1dkM1WjNLY0RPYlI4QWJHdTJnblpIRFpPTWE4OTJuOWhFUzl2LXVtSk5YQXFhMjF2cW9LWHpFOFlUdFBZY1E?oc=5" target="_blank">New HIV Vaccine Shows Unprecedented Success in Preclinical Study</a>&nbsp;&nbsp;<font color="#6f6f6f">POZ</font>
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQcmZOWXJhcDRYak82NlRZOTdXUy1weC0xOWV5QmVDR181bkZ4MFJXUjhUenU3eDd4WGpYcko4ZzBuY3ZneERRYjVjdHM4YWFod0JnSnFkTEdYTXBIU2lDRjBjVUpJOXFkSngtelQzSW1CaC10SGlhRk05N1MxV0VLVVB2bzZNQlgydFpGVkdpR1hRNkN1RmFjZkVxNTRzeEJ3RTlTTFFIMA?oc=5" target="_blank">Oncodesign Services and Nexus BioQuest partner on preclinical drug development</a>&nbsp;&nbsp;<font color="#6f6f6f">Manufacturing Chemist</font>
<a href="https://news.google.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?oc=5" target="_blank">Recludix Pharma to Present Preclinical Asthma and</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1wUHAxRnFoNzZWSHNESjhta1dNMC1QZjlvVHI4T1NKeEwtSUVONHh1Qy01RzdqXy1XQm10aVJKRDVNU3pZZ3ZfUWs1dndKRmlLS2NsWElqNnljWk1pZkVn?oc=5" target="_blank">Preclinical immunological characterization of rademikibart (CBP-201), a next-generation human monoclonal antibody targeting IL-4Rα, for the treatment of Th2 inflammatory diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>